Syngene's Bengaluru unit passes US FDA test with VAI classification
An FDA inspection, which took place between February 10-20, concluded with a classification of voluntary action indicated (VAI). Shares of Syngene International Ltd ended at ₹652.45, down by ₹10.45, or 1.58%, on the BSE.

What's Your Reaction?






